Photoacoustic imaging of human coronary atherosclerosis in two spectral bands  by Jansen, Krista et al.
Photoacoustics 2 (2014) 12–20Research Article
Photoacoustic imaging of human coronary atherosclerosis in two
spectral bands
Krista Jansen a,b,1, Min Wua, Antonius F.W. van der Steen a,b,c, Gijs van Soest a,*
aDepartment of Biomedical Engineering, Erasmus MC, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands
b Interuniversity Cardiology Institute of The Netherlands – Netherlands Heart Institute, P.O. Box 19258, 3501 DG Utrecht, The Netherlands
cDepartment of Imaging Science and Technology, Delft University of Technology, Lorentzweg 1, 2628 CJ Delft, The Netherlands
A R T I C L E I N F O
Article history:
Received 18 September 2013
Received in revised form 29 October 2013
Accepted 16 November 2013
Keywords:
Intravascular imaging
Atherosclerosis
Vulnerable plaque
Tissue characterization
Spectroscopy
Lipids
A B S T R A C T
Spectroscopic intravascular photoacoustic imaging (sIVPA) has shown promise to detect and distinguish
lipids in atherosclerotic plaques. sIVPA generally utilizes one of the two high absorption bands in the
lipid absorption spectrum at 1.2 mm and 1.7 mm. Speciﬁc absorption signatures of various lipid
compounds within the bands in either wavelength range can potentially be used to differentiate
between plaque lipids and peri-adventitial lipids. With the aim to quantify any differences between the
two bands, we performed combined sIVPA imaging in both absorption bands on a vessel phantom and an
atherosclerotic human coronary artery ex vivo. Lipid detection in a human atherosclerotic lesion with
sIVPA required lower pulse energy at 1.7 mm than at 1.2 mm (0.4 mJ versus 1.2 mJ). The imaging depth
was twice as large at 1.2 mm compared to 1.7 mm. Adequate differentiation between plaque and peri-
adventitial lipids was achieved at 1.2 mm only.
 2013 The Authors. Published by Elsevier GmbH. 
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Myocardial infarction is a leading cause of death worldwide [1].
In the majority of cases, they are caused by the rupture of an
atherosclerotic plaque and the subsequent release of its thrombo-
genic content into the bloodstream [2]. The presence of a lipid rich
necrotic core is one of the determinants of the susceptibility of a
plaque to rupture [3,4]. For that reason, the identiﬁcation of
necrotic core is a highly coveted imaging target. Intravascular
ultrasound (IVUS) radiofrequency data analysis techniques for
tissue characterization (VH-IVUS, iMap) have been developed, but
their accuracy and mutual consistency are still under investigation
[5–7]. Near infrared spectroscopy (NIRS) in combination with IVUS,
can identify the presence but not the amount or location, relative
to the lumen, of the lipid core [8–10].
Intravascular photoacoustic (IVPA) imaging has demonstrated
the ability to directly image tissue components in the vessel wall,
with high chemical speciﬁcity for lipid type. It utilizes differences* Corresponding author. Tel.: +31 10 70 44638; fax: +31 10 70 44720.
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Open access under CC BY liin the absorption spectra of the vessel wall constituents to identify
tissue types. Efforts have primarily concentrated on lipid detection,
and started in the visible wavelength range. With the introduction of
suitable light sources, focus shifted to the near-infrared wavelength
range, where hemoglobin absorption is much lower, allowing for
better light penetration. In this wavelength range, the absorption
spectra of lipids are characterized by two prominent features around
1.2 and 1.7 mm. These absorption bands are the result of the second
and ﬁrst overtones of the C–H bond vibrations within the lipid
molecules, respectively. The 1.2 mm absorption band has been
exploited extensively to distinguish lipids from healthy vessel wall,
in rabbit [11,12] as well as human [13–15] atherosclerotic arteries.
In recent years, lipid detection using excitation wavelengths around
1.7 mm has seen increased interest [13,16–18]. In this wavelength
range, the higher lipid absorption possibly leads to increased
sensitivity using lower light intensity. However, water absorption is
higher too, which could potentially offset the increased sensitivity
for lipids by limiting the penetration depth (Fig. 1).
Both absorption bands each consist of several overlapping
peaks as a result of C–H bond vibrations within the different
structural groups (–CH3, >CH2, BBCH and >CH (aromatic)) of the
lipid molecules [19–21]. The position and relative height of the
peaks vary with the number and location of these different
structural groups within the molecules and therefore provide
chemical speciﬁcity. The possibility for differentiating between
plaque lipids and peri-adventitial lipids, based on the speciﬁccense.
Fig. 1. (a) Lipid and water absorption in the near-infrared wavelength region, showing the two high peaks in the lipid absorption spectrum around 1210 and 1720 nm. In these
two optical windows, lipid absorption exceeds water absorption. Lipid absorption at 1720 nm is 5.5 times higher than at 1210 nm; water absorption is 5 times higher.
Adapted from [22]. (b) Transmission of light through water; computed based on data from http://omlc.ogi.edu/spectra/water/abs/index.html.
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explored.
These considerations outline tradeoffs in terms of sensitivity,
imaging depth, and possibly chemical speciﬁcity connected to the
choice of IVPA wavelength. In this paper, we present spectroscopic
IVPA (sIVPA) imaging of a lipid containing vessel phantom and an
atherosclerotic human coronary artery ex vivo at 1.2 mm and
1.7 mm, providing a direct comparison between the wavelength
ranges. In the phantom, we acquired high-resolution spectra of
cholesterol, cholesterol oleate and cholesterol linoleate, represen-
tative of plaque lipids, and peri-adventitial tissue. The resulting
spectra were used to determine a limited number of wavelengths
that maximize the difference between plaque and peri-adventitial
lipids. At these wavelengths, we obtained co-registered sIVPA/
IVUS images of the vessel phantom that we used to detect the
plaque and peri-adventitial lipids alternatively. With two wave-
lengths per spectral range only, the lipid detection capability in
each range was examined using both the phantom data and the ex
vivo data of a diseased human coronary artery specimen.
2. Methods
2.1. Phantom design
To determine the capacity for lipid detection and differentiation
at 1.2 and 1.7 mm, we made a cylindrical vessel mimicking phantom
(Fig. 1a). The phantom consisted of 10% (by weight) poly-vinyl-
alcohol (PVA) crystals in demineralized water that formed an
acoustically transparent gel after 2 freeze/thaw cycles. It had a
central lumen with a diameter of 3 mm and four 5 mm deep
cylindrical cavities with a diameter of 1.5 mm, located at 500 mm
from the lumen. We ﬁlled three cavities with cholesterol, cholesterol
oleate and cholesterol linoleate (Sigma Aldrich Co., C8667, C9253
and C0289, resp.). These are the three most abundantly present
lipids in atherosclerotic lesions [23,24], and are assumed to be
representative of plaque lipids. The fourth cavity was ﬁlled with
peri-adventitial tissue that was obtained from a human coronary
artery specimen, see description below. In peri-adventitial tissue,
lipids are deposited as a mixture of fatty acids [25].
2.2. Human artery acquisition and handling
A human coronary artery was collected at autopsy from the
Department of Pathology of the Erasmus Medical Center (MC),
after obtaining consent from the relatives and approval of the
research protocol by the Medical Ethics Committee of the Erasmus
MC (MEC-2007-081). The coronary artery was frozen within 4 h at80 8C and stored. It was thawed and measured three months
later.
2.3. Combined intravascular photoacoustic and ultrasound imaging
system
All co-registered sIVPA/IVUS images were acquired using a
combined IVPA/IVUS imaging system described previously [14].
The excitation light for photoacoustic imaging was supplied by a
tunable laser (OPOTEK Vibrant B/355-II) with a pulse duration of
5 ns and a repetition rate of 10 Hz. The laser was coupled to the
custom-built catheter by a tapered multimode ﬁber (Oxford
Electronics, Four Marks, UK; input diameter 1 mm; output
diameter 360 mm).
The hybrid IVPA/IVUS catheter prototype we used is similar to
those used earlier [14], but with a different transducer. It
comprised a 400 mm diameter core optical ﬁber (Pioneer Optics,
Bloomﬁeld, CT) to deliver the light pulses to the vessel wall. The
ﬁber tip was polished under a 348 angle covered by a quartz cap to
maintain an air–glass interface deﬂecting the beam by total
reﬂection. An ultrasound transducer was placed distal from the
ﬁber tip to transmit and receive ultrasound waves. The 0.4 by
0.4 mm lead magnesium niobate-lead titanate (PMN-PT) single
crystal ultrasound transducer was designed and custom built by
the Department of Biomedical Engineering of the University of
Southern California [26] and had a center frequency of 44.5 MHz
and a 6 dB fractional bandwidth of 45%. The separation between
ﬁber tip and transducer center was approximately 1 mm; the
optical and acoustical beam overlapped between 0.5 and 4.5 mm
from the transducer, with an angle of 228. The catheter tip
assembly had an outer diameter of 1 mm.
The catheter was rotated using a motorized rotary stage
(Steinmeyer GmbH & Co. KG). For pulse echo imaging, an arbitrary
waveform generator (Tabor Electronics WW2571A) transmitted a
Gaussian-modulated cosine wave which was transmitted to the
probe through a custom-built expander and limiter. Received US
and PA signals were band pass ﬁltered (13–60 MHz 5th order
Butterworth, custom built), ampliﬁed by a 43 dB ampliﬁer (Miteq
AU1263) and digitized at a sample frequency of 350 MS s1 by a
12-bit data acquisition card (Acqiris DP310).
2.4. Phantom measurements
Using the dual modality imaging system described above, we
imaged the lipid containing vessel phantom in a water bath, with
the combined IVPA/IVUS catheter positioned in the lumen. We ﬁrst
acquired a cross sectional IVUS image to locate the lipid inclusions.
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1125 to 1275 nm and from 1620 to 1780 nm in steps of 2 nm, to
determine the PA spectra of each lipid compound. At every
wavelength, 32 image lines were recorded. The average pulse
energy at the catheter tip was 1.2 mJ in the 1.2 mm and 0.4 mJ in
the 1.7 mm spectral range. By staying within a relatively narrow
spectral window, the average laser pulse energy and tissue
scattering properties could be assumed constant within each
wavelength range. The resulting spectra were normalized to the
peak value and analyzed to determine the wavelengths most
suitable to distinguish plaque from other lipids: per wavelength
range, 4 wavelengths for which the cholesterol spectrum differed
most from the spectrum of peri-adventitial lipids were selected,
after which 2 wavelengths were added to create a fairly distributed
spacing.
Next, we obtained two-dimensional spatially co-registered
spectroscopic IVPA and IVUS images of the phantom at these 12
wavelengths (6 per wavelength range) by rotating the catheter in
18 steps and acquiring photoacoustic and ultrasound image lines at
every step. At every angle, the laser was tuned through the spectral
range of interest (1.2 and 1.7 mm) to ensure co-registration of the
IVPA data at all wavelengths. For ultrasound pulse echo imaging,
we transmitted a 10 V peak to peak Gaussian-modulated cosine
wave with a center frequency of 44.5 MHz and a 50% 6 dB
bandwidth relative to the peak. IVUS images were obtained by
averaging the echoes from 8 transmissions per line; IVPA was not
averaged (one laser pulse per wavelength per image line).
2.5. Artery measurements
The human coronary artery was placed in a TPX (TPX1
Polymethylpentene) holder with 200 mm thick metal wires glued
at every 1.5 mm perpendicular to the longitudinal axis to provide
image registration. The holder was then placed in a water tank
containing a saline solution at room temperature. The artery was
tied on a cannula through which the catheter was introduced. To
ﬁnd sites of interest, we performed an IVUS pullback using a
commercial IVUS system (Boston Scientiﬁc iLab, Atlantis SR Pro
catheters), using the metal wires as reference points. The selected
wires were then found using our combined IVPA/IVUS catheter.
Spatially co-registered sIVPA/IVUS cross sectional images were
obtained by rotation of the catheter in 18 steps and acquiring
photoacoustic and ultrasound image lines at every step. Two
rotations were performed to obtain two co-registered images at
1205 and 1235 nm, and at 1680 and 1710 nm, separately. At every
angle, the laser was tuned from 1205 to 1235 nm in the ﬁrst
measurement, and from 1680 to 1710 nm in the second
measurement, to ensure co-registration of the IVPA data per
wavelength range. The ultrasound signal transmitted for pulse
echo imaging, as well as the number of averaging and the average
pulse energy, were the same as in the phantom measurement.
2.6. IVPA spectral data processing
The digitized spectroscopic IVPA data of the four lipid inclusions
in the phantom, were band pass ﬁltered between 10 and 70 MHz
using a 100th order zero-phase forward and reverse ﬁnite impulse
response (FIR) ﬁlter, and subsequently upsampled, corrected for
jitter and downsampled to the original sampling frequency. Next, a
Tukey window and envelope ﬁlter were applied. A correction for
variations in the light energy was employed, using the amplitude
of the signal close to the transducer, which is caused by the
absorption of laser pulses in the ultrasound transducer and
catheter tip. Depth locations of high signal intensity were chosen
by selection of all peaks above a certain threshold in the 1205 and
1710 nm enveloped signal traces, respectively. Spectra at selectedlocations were ﬁltered using a fourth order digital smoothing
polynomial (Savitzky–Golay) ﬁlter, 32 times averaged and
normalized.
2.7. sIVPA/IVUS image reconstruction
The digitized IVPA and IVUS rotational data band pass ﬁltered
and jitter corrected like the spectroscopic scans described above.
The 1.2 mm wavelength range IVPA data of the artery cross section
where subsequently median ﬁltered over 5 image lines in the
angular direction for extra noise reduction.
An adaptive ﬁlter was designed and applied to all rotational
IVPA data to remove the artifact that was caused by the absorption
of laser pulses in the ultrasound transducer and catheter tip. It
presents in the IVPA image as bright rings, concealing the
photoacoustic signals produced by the arterial tissue close to
the catheter. A similar circular artifact in the IVUS data, caused by
the ‘ringing’ of the transducer as a result of the transmission of
ultrasound pulses, was removed by subtracting the mean in the
angular direction of the affected part of the data. Both the IVPA and
IVUS data were then Tukey windowed and envelope ﬁltered. A
correction for variations in the light energy between individual
pulses and between the different wavelengths, using the ampli-
tude in the ring artifact mentioned above, was applied to the IVPA
data. We subsequently scan-converted the IVPA and IVUS data to
Cartesian coordinates and log compressed them for display. The
‘hot’ and ‘gray’ colormaps in Matlab (R2007b) were used for the
IVPA and IVUS images, respectively. To create combined IVPA/IVUS
images, we overlaid the IVPA data on the IVUS images using a
nonlinear red-yellow-white color scale and a linear transparency
scale. All data processing was done using Matlab (R2007b).
2.8. sIVPA data analysis for lipid differentiation and detection
To investigate the capability of sIVPA in the two absorption
bands to distinguish plaque from peri-adventitial lipids, the two 6-
wavelength sIVPA data sets of the lipid containing vessel phantom
were processed as described above, up to scan-conversion. For
each pixel in the resulting data sets, the correlation coefﬁcient R of
the PA spectrum with two reference spectra was computed. We
used the PA spectra of cholesterol and peri-advential tissue as
reference spectra for plaque and peri-adventitial lipids, respec-
tively. Of the plaque lipid spectra (Fig. 2c and d), in either spectral
range, the cholesterol spectrum has the lowest correlation with the
peri-adventitial spectrum (Fig. 2b) and therefore is the most
suitable to distinguish plaque from other lipids.
The 6-wavelength correlation coefﬁcients Rx (x is lipid type;
‘‘chol’’ for cholesterol or ‘‘PL’’ for peri-adventitial lipids) were
median ﬁltered over 48 in the angular direction and 8 samples in
the radial direction. The threshold values Rc,x for the correlation
coefﬁcients were chosen empirically: the lowest values for which
plaque lipids could still be separated from peri-adventitial lipids
were selected. To create a lipid map, the lipid matching regions–
those with a correlation coefﬁcient equal to or higher than the
threshold value Rc,x – were displayed in red and overlaid on the
corresponding IVUS image.
We compared the potential of sIVPA at 1.2 mm and at 1.7 mm
for lipid identiﬁcation using two wavelengths, lh,v and ll,v (h for
high lipid absorption; l for low lipid absorption) per wavelength
range v. We computed lipid maps of the phantom and artery cross
section using the following algorithm: we determined the noise
level at lh,v by sampling the PA signal inside the lumen (identiﬁed
in the IVUS image) and masked out all PA signal below that level.
We then calculated the relative difference dv = [I(lh,v)  I(ll,v)]/
I(lhv), where I(l) is the PA signal amplitude at wavelength l. d was
subsequently median ﬁltered over 48 angular by 8 samples radial.
Fig. 2. Lipid containing vessel phantom and IVPA spectra of lipid inclusions. (a) Photograph of the phantom (top-view), ﬁlled with cholesterol (bottom), cholesterol oleate
(right), cholesterol linoleate (top) and peri-adventitial tissue (left). (b) 6-Wavelength correlation coefﬁcients between the spectra of the lipid inclusions. (c) Average,
normalized PA spectra of the four lipid inclusions in the 1.2 mm wavelength range, and (d) in the 1.7 mm wavelength range. c, cholesterol; cl, cholesterol linoleate; co,
cholesterol oleate; pl, peri-adventitial lipids.
Table 1
Wavelengths used for 6-wavelength lipid detection.
Wavelength range (mm) Wavelengths (nm)
1.2 1185, 1195, 1205, 1215, 1225, 1235
1.7 1680, 1710, 1718, 1726, 1734, 1751
K. Jansen et al. / Photoacoustics 2 (2014) 12–20 15Lipids were identiﬁed by d > dc, where dc are the threshold values
determined from the analysis of the absorption spectra of pure
lipids, see Figs. 2c and d and 5.
2.9. Histological validation
After imaging, we cut the artery at the two wires adjacent to the
imaging plane to obtain a 3 mm thick artery segment with the
imaged cross-section in the middle. The segment was embedded in
‘‘optimal cutting temperature’’ (OCT) compound (Tissue-Tek1,
Sakura Finetek Europe B.V.), frozen in liquid nitrogen cooled
isopentane vapor, and stored at 80 8C until serial sectioning for
staining. We performed Oil Red O (ORO) staining to identify lipids
(stained red). A Hematoxylin–Eosin (H&E) stain was used to
provide an overview of the artery cross section; a Resorcin–Fuchsin
(RF) stain was used to demonstrate the morphology and ﬁbrous
structure of the vessel cross-sections.
3. Results
3.1. Lipid differentiation in phantom
We performed sIVPA measurements in the directions indicated
by the white dashed lines in the photograph (top view) of the
phantom in Fig. 2a. The data were analyzed as described in Section
2.6 and the resulting averaged normalized PA spectra of
cholesterol, cholesterol oleate, cholesterol linoleate and peri-
adventitial tissue in the 1.2 and 1.7 mm wavelength range are
shown in Fig. 2c and d, respectively. While the spectra at 1.2 mm
exhibit mainly differences in relative peak height, the dominantdifferences at 1.7 mm are shifts in the locations of the peaks
between the spectra of plaque and peri-adventitial lipids.
We obtained cross sectional sIVPA/IVUS data of the lipid-
containing vessel phantom at 6 wavelengths in both spectral
ranges. The wavelengths are given in Table 1. The lipid maps
resulting from the correlation of the data in the 1.2 mm range with
the cholesterol and the peri-adventitial lipid reference spectrum
are displayed in Fig. 3a and b, respectively; The corresponding lipid
maps obtained in the 1.7 mm range are shown in Fig. 3c and d,
respectively. All lipid maps are overlaid on the associated, co-
registered IVUS image. At 1.2 mm, the cholesterol and the two
cholesterol esters, representative of plaque lipids, are all detected
clearly, while the peri-adventitial tissue remained concealed
(Fig. 3a). At 1.7 mm, however, it was not possible to simultaneously
detect the cholesterol oleate and keep the peri-adventitial tissue
invisible. On the other hand, more of the cholesterol was detected
than at 1.2 mm. The correlation with the peri-adventitial reference
spectrum resulted in detection of the peri-adventitial tissue in the
1.2 mm wavelength range, while suppressing the other lipids
(Fig. 3b). In the 1.7 mm wavelength range, less of the peri-
adventitial tissue was detected (Fig. 3d).
Table 2 lists the threshold correlation values Rc,x for the 6-
wavelengths at 1.2 and 1.7 mm that were used to create the lipid
maps in Fig. 3a–d. To be able to detect peri-adventitial lipids while
Fig. 3. Lipid typing in a lipid-containing vessel phantom using sIVPA at 1.2 and 1.7 mm. (a) Lipid map based on 6-wavelength correlation with the cholesterol, and (b) with the
peri-adventitial reference spectrum in the 1.2 mm wavelength range (1185, 1195, 1205, 1215, 1225 and 1235 nm). (c) Lipid map based on the 6-wavelength correlation with
the cholesterol, and (d) with the peri-adventitial reference spectrum in the 1.7 mm wavelength range (1680, 1710, 1718, 1726, 1734 and 1751 nm). All lipid maps are shown
overlaid on the corresponding IVUS image (dynamic range 65 dB). Plaque lipids, represented by cholesterol (bottom), cholesterol oleate (right) and cholesterol linoleate (top)
are distinguished clearly from peri-adventitial tissue (left) at 1.2 mm, while lipid typing at 1.7 mm yielded an inferior result.
K. Jansen et al. / Photoacoustics 2 (2014) 12–2016suppressing plaque lipids, the correlation coefﬁcients had to be
chosen much higher for the 1.7 than for the 1.2 mm wavelength
range.
3.2. Lipid detection in phantom and artery
We investigated the ability of sIVPA to detect lipids using two
wavelengths at 1.2 mm versus the 1.7 mm, in both the lipid
containing vessel phantom and a human coronary artery ex vivo.
The phantom results are shown in Fig. 4. The co-registered
combined IVPA/IVUS images at 1205 (high lipid absorption) and
1235 nm (low lipid absorption) and the resulting relative
difference lipid map, are displayed in Fig. 4a–c, respectively.
Fig. 4d–f depicts the corresponding high and low lipid absorption
images in the 1.7 mm wavelength range, at 1710 and 1680 nm, and
lipid map, respectively. In both wavelength ranges, all four lipid
containing cavities exhibit an increased PA signal at lh compared
to the PA signal at ll. In the 1.2 mm range IVPA images, however, a
higher signal can be observed from non-lipid regions, compared to
the 1.7 mm range IVPA images, due to the overall higher light
ﬂuence. Both lipid maps succeed equally well in displaying theTable 2
Threshold values Rc,x and dc.
Threshold variable Wavelength range (mm)
1.2 1.7
Rc,chol 0.87 0.88
Rc,PL 0.88 0.96
dc 0.37 0.23peri-adventitial lipid region but the plaque lipids were displayed
more clearly in the 1.7 mm wavelength range.
The false positives in the 1.7 mm lipid map at 2 times the
distance of the lipids from the catheter are the result of incomplete
suppression of the pulse echo signal that is generated by
absorption of the light in the transducer and catheter tip. This
ultrasound signal is also visible in the 1.2 mm range but is
effectively suppressed, as well as the higher PA background signal.
The threshold values dc to realize the lipid maps in Fig. 4c and f,
were chosen using the spectral data of the separate lipid
compounds. The 5th to 95th percentile of the relative difference
of the PA signal at high and low lipid absorption wavelengths of the
individual (unaveraged) IVPA spectra measured in the lipid
containing phantom were calculated (Fig. 5). The relative
difference of the absorption coefﬁcient of elastin and collagen at
these wavelengths, is shown as well. Threshold values were chosen
as the midpoint between the lowest value found for the lipids and
the highest value found for elastin and collagen (red dotted line).
The resulting threshold values dc in both wavelength are listed in
Table 2.
The results of the atherosclerotic human coronary specimen
(left anterior descending artery, male aged 65) measurement are
shown in Fig. 6. The top row, Fig. 6a–c, displays the results obtained
in the 1.2 mm wavelength range; the bottom row, Fig. 6d-f, the
results obtained using wavelengths around 1.7 mm. From left to
right, the IVPA images at lh, the IVPA images at ll, and the 2-
wavelength relative difference lipid maps are shown. All images
are overlaid on the corresponding IVUS image. The IVUS images
show a small lumen with an eccentric plaque at the bottom right of
the vessel wall. A large calciﬁcation is present in the plaque,
Fig. 4. Lipid detection in a lipid-containing vessel phantom using sIVPA at 1.2 and 1.7 mm. (a) 1205 nm and (b) 1235 nm combined IVPA/IVUS images (IVPA 50 dB, IVUS 65 dB)
of PVA phantom ﬁlled with cholesterol (bottom), cholesterol oleate (right), cholesterol linoleate (top) and peri-adventitial tissue (left). (c) Lipid map based on 2-wavelength
relative difference between the PA signal at 1205 nm and 1235 nm. (d). Co-registered 1710 nm and (e) 1680 nm combined IVPA/IVUS images (IVPA 50 dB, IVUS 65 dB) of the
same cross section of the vessel phantom. (f) Lipid map resulting from the 2-wavelength relative difference between the PA signal at 1710 nm and 1680 nm. Both lipid maps
are shown overlaid on the corresponding IVUS image.
K. Jansen et al. / Photoacoustics 2 (2014) 12–20 17indicated by the shadowing in the plaque area. The ORO lipid stain,
depicted in Fig. 6g, conﬁrms these ﬁndings (lipids in red;
calciﬁcation black). The 1205 nm IVPA image shows a slightly
enhanced signal from the lipid area in the top part of the plaque, as
well as a strongly enhanced signal in the peri-adventitial region
around the vessel wall, compared to the 1235 nm IVPA image. In
the 1.7 mm range, the enhancement of the signal in the lipid rich
plaque area is more pronounced than in the 1.2 mm range, while
the signal enhancement in the peri-adventitial region is compara-
ble. Additionally, the calciﬁed region produces much less signal
around 1.7 mm, albeit still in the same order of magnitude as the
signal produced by the plaque lipids. In accordance with the0
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Fig. 5. Relative difference of PA signal at high and low lipid absorption wavelengths of ind
to 95th percentile of the relative difference of the 1205 nm and 1235 nm PA signal streng
(32, 128, 160 and 96 spectra, respectively). Data for elastin and collagen are obtained 
1235 nm PA signal strength of same lipid components (same number of spectra). Elast
linoleate; co, cholesterol oleate; pl, peri-adventitial lipids.differences found by visual inspection of the IVPA images, both
lipid maps indicate lipids in the top part of the lesion, as well as in
the peri-adventitial tissue region around the vessel wall. In the
1.7 mm lipid map however, more intraplaque lipids are detected,
due to the higher signal enhancement and therefore better signal
to noise ratio. The signal from the calciﬁcation is suppressed
successfully in both cases. The enlargements of the ORO lipid stain
(Fig. 6e and f) of the area indicated as lipid rich in the lipid maps
reveal the presence of larger extracellular lipid droplets, whereas
the lipids in all other parts of the lesion are intracellular or
contained in small extracellular droplets. This preferential detec-
tion is possibly caused by a higher Gru¨neisen coefﬁcient, a higher0
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(b)
ividual (unaveraged) IVPA spectra measured in the lipid containing phantom. (a) 5th
th of cholesterol, cholesterol oleate, cholesterol linoleate and peri-adventitial lipids
from [25]. (b) 5th to 95th percentile of the relative difference of the 1205 nm and
in data obtained from [27]; collagen data from [28]. c, cholesterol; cl, cholesterol
Fig. 6. Lipid detection in an atherosclerotic human coronary artery using sIVPA at 1.2 and 1.7 mm. (a) 1205 nm and (b) 1235 nm combined IVPA/IVUS images (IVPA 25 dB,
IVUS 40 dB). (c) Lipid map based on 2-wavelength relative difference between the PA signal at 1205 nm and 1235 nm. (d). 1710 nm and (e) 1680 nm combined IVPA/IVUS
images (IVPA 25 dB, IVUS 40 dB). (f) Lipid map resulting from the 2-wavelength relative difference between the PA signal at 1710 nm and 1680 nm. Both lipid maps are shown
overlaid on the corresponding IVUS image. (g) Lipid histology stain (ORO); lipids are stained red; calciﬁcation is stained black (h) 5 magniﬁcation of the part of the
atherosclerotic plaque indicated as lipid rich by the lipid stains (area outlined in black in (g)), shows larger extracellular lipid droplets, while the lipids in all other parts of the
lesion are intracellular or contained in small extracellular droplets. (i) 4 magniﬁcation of area outlined in black in (h).
K. Jansen et al. / Photoacoustics 2 (2014) 12–2018concentration of the lipids or a better matching of the generated PA
signal frequency to the bandwidth of the transducer.
The data presented here (in Figs. 3, 4 and 6) show that the
maximum lipid imaging depth at 1.2 mm is approximately twice as
large compared to 1.7 mm. The exact numerical value depends on
the optical (scattering and absorption) and acoustic (frequency-
dependent attenuation) properties of the tissue. At 1.2 mm, lipid
signal was received from tissue layers in the artery wall at a depth
of 5 mm.
4. Discussion and summary
This study assesses the lipid detection and distinction
capabilities of spectroscopic intravascular photoacoustic imaging
in two absorption bands, around 1.2 mm and 1.7 mm. We acquired
co-registered sIVPA/IVUS data of a lipid containing vessel phantom
at 6 wavelengths in either spectral window. Correlation with a
cholesterol PA spectrum, as reference for atherosclerotic lipids, and
with a peri-adventitial tissue reference spectrum, using 6
wavelengths from 1185 to 1235 nm, distinguishes very well
between atherosclerotic lipids and peri-adventitial lipids. The
same 6-wavelength correlation method applied on sIVPA data
from 1680 to 1751 nm resulted in a poorer separation of in
particular cholesterol oleate and peri-adventitial tissue. Applying a
2-wavelength relative difference method, we successfully detectedall four lipid compounds present in the vessel phantom in both
wavelength ranges, with a superior detection of all four lipids in
the 1.7 mm region. In an ex vivo sIVPA/IVUS measurement of an
human coronary artery, we found superior plaque lipid contrast in
the 1.7 mm wavelength range, with a lower pulse energy (0.4 mJ
versus 1.2 mJ at 1.2 mm) and sufﬁcient imaging depth (for this
particular vessel cross section). Low pulse energy is an advantage
because it lowers the optical power that needs to be dissipated in
vivo, and also reduces artifacts in IVPA imaging caused by light
absorption in the catheter.
The relative difference between two wavelengths is a robust
parameter to detect the lipids, also in the presence of strong water
absorption in the longer wavelength band, as long as the signal
received from the lipids is above the noise level. Note that a
minimum of two wavelengths is required in both the 1.2 mm and
the 1.7 mm wavelength range to distinguish lipids from other
vessel wall constituents; the IVPA signal generated by calcium is in
the order of magnitude of the signal from lipids around 1.7 mm and
even higher around 1.2 mm.
Minimization of the required number of wavelengths is
important for clinical application: the acquisition speed is
inversely proportional to the number of PA acquisition needed
to compose an image line. Light sources are expected to represent a
signiﬁcant fraction of the cost of an IVPA system for clinical
applicability, presenting another reason to limit the number of
K. Jansen et al. / Photoacoustics 2 (2014) 12–20 19wavelengths. We demonstrated here that two wavelengths are
sufﬁcient, in principle, to detect lipids, but not to differentiate.
Noise reduction in the acquisition and more sophisticated analysis,
targeted to exploit spectral differences between the various lipid
tissues, may yield more insight from a two-wavelength combina-
tion.
This study is qualitative in design, exploring several analysis
methods applied to the different lipid absorption bands for lipid
detection and differentiation by sIVPA. A larger quantitative study
will be performed in the future to determine the most favorable
wavelengths and the appropriate parameters used for processing.
Such a study could also establish whether the imaging depth at
1.7 mm is sufﬁcient to image the vessel wall of larger coronary
arteries, such as the left main stem, completely. A larger ex vivo
study will also elucidate the representativeness of pure cholester-
ol, cholesterol oleate, and cholesterol linoleate for the absorption
spectra of real atherosclerosis. It will provide insight into the
natural variability of the absorption spectrum, which the eventual
choice of wavelength combinations will have to take into account.
Photoacoustic imaging seems to favor the detection of larger
extracellular lipid droplets. To quantify the sensitivity of sIVPA to
the different forms and sizes of intraplaque lipids, a statistical
analysis of a larger data set should be performed.
In summary, we presented the lipid detection and typing
capabilities of 1.2 mm and 1.7 mm sIVPA. We observed superior
lipid differentiation in the shorter wavelength range in a lipid
containing vessel phantom. In the longer wavelength range,
however, intraplaque lipid detection was improved, both in the
vessel phantom as well as in an atherosclerotic human coronary
artery, with lower pulse energy.
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